TrialAddiction (Abingdon, England)2017

Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trial.

Philip T Korthuis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.